Class III · Low risk Ongoing
Glimepiride Tablets
Reason Misprint on tablet
Glimepiride Tablets USP
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.
What was recalled
GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21.
- Recalling firm
- Qualitest Pharmaceuticals
- NDC code
- 0603-3745-21
- Origin
- AL, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-298-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Glimepiride recalls
See all
Class III · Low risk Ongoing
Glimepiride Tablets
Reason Misprint on tablet
Class II · Moderate risk Terminated
Glimepiride USP
Reason CGMP deviations.
Class II · Moderate risk Ongoing
Glimepiride Tablets USP
Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk Ongoing
Glimepiride Tablets
Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.